InvestorsHub Logo
Followers 9
Posts 776
Boards Moderated 0
Alias Born 07/15/2017

Re: Bill B post# 328662

Monday, 03/08/2021 9:26:49 AM

Monday, March 08, 2021 9:26:49 AM

Post# of 425849
Bill

They’ve got a number of patents which is good. However, aren’t the patents utility and value limited to their ability to be used in a medical setting ? As in Amarin needs to run long expensive trials to provide evidence of efficacy for Vascepa to treat not only CVD but also the list of patented treatments on their list of IP.

I mention it as not to get too excited about a patent until there’s proof in the results that this is a potential new indication. Which takes years and money to fund the trials.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News